EORTC protocol 08962

A phase III study of Marimastat in patients with small cell lung cancer following a response to first line chemotherapy.
Trial StatusAll trial activities ended
DatesDate of activation: 17-Mar-97
Closed on : 21-Dec-99
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size240
Number of steps1
Drug
Study StaffGiuseppe Giaccone (Study Coordinator) - National Cancer Institute - National Institute of Health, Bethesda
Type of cancerLung
Participating GroupsNCIC Clinical Trial Group(Coordinating Group)
EORTC Lung Cancer Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00003011
EudraCT
Back to Protocol section